Postdoctoral Research Associate

Research Interests:

Engaged in the research project, Role of Histone H3 phosphorylation in breast and prostate cancer. Specifically, focusing in two major tasks: 1. To examine the mechanistic details of Histone H3 phosphorylation signaling nexus and its effect on immune modulation upon inhibitor treatment; 2. To evaluate therapeutic efficacy of combining tyrosine kinase inhibitors with immune checkpoint blockade in breast and prostate cancer preclinical animal models.

Selected Publications:
  1. Wang ZH, Ng HI, Teng CS, Ge ZC, et al. Outcomes of single-port gasless laparoscopic breast-conserving surgery for breast cancer: An observational study. Breast J. 2019 Apr 3.
  2. Wang ZH, Qu X, Teng CS, Ge ZC, et al. Preliminary results for treatment of early stage breast cancer with endoscopic subcutaneous mastectomy combined with endoscopic sentinel lymph node biopsy in China. Journal of Surgical Oncology. 2016, 113(6): 616-620.
  3. Zhang H, Qu X, Ma X, Wang T, Yang Y, Ge Z, Zhang Z, Bai Z, Gao Y, Yuan Z, Wang ZH*. TXR1 and TSP1 expression varies by the molecular subtypes of breast cancer patients who received previous docetaxel-based first-line chemotherapy. Exp Biol Med (Maywood). 2016, 241(17):1919-1923.

Zihan Wang

MD, Capital Medical University, Beijing

Contact: 

Phone: 314-273-7759